EU approves Biocon Biologics’ Denosumab biosimilars
Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
marketing authorisation
Venus Remedies secures marketing authorisation for Enoxaparin in Indonesia
Approval expands company’s footprint in Southeast Asia’s growing anticoagulant market
Sanofi India receives marketing authorisation for Rezurock in India
Belumosudil Tablets approved for chronic graft-versus-host disease treatment
Glenmark partners with Pfizer to launch Abrocitinib in India
When launched in India, it will be co-marketed under the brand names JABRYUS and CIBINQO by Glenmark and Pfizer respectively
Orchid Pharma gets EMA approval for Exblifep
Exblifep has received EMA's recommendation for marketing authorization for use in treatment of complicated urinary tract…
Venus Remedies gets marketing approval from Israel, Colombia for two oncology drugs
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Venus Remedies gets marketing approvals from Philippines, Saudi Arabia for three drugs
While Saudi Arabia is the largest pharma market in GCC region, Philippines happens to be the second largest market in South East…
Biocon Biologics gets EC approval for YESAFILI, biosimilar Aflibercept
The EC decision follows the European Medicines Agency’s CHMP positive opinion recommending approval of YESAFILI in July
Venus Remedies gets marketing approval for gemcitabine and docetaxel from Serbia
With this, the company has secured 511 marketing approvals for its oncology products across 66 countrles
Venus Remedies gets marketing approval from Saudi for Docetaxel
This marketing authorisation from the largest GCC market will enable Venus Remedies to establish a strong foothold in GCC and MENA…